Join me as I sit down with Dr. Hamid Khoja, Ph.D. His newest research is looking at using fibroblast cell therapy to help slow the progression of MS as well as potentially remyelinate and recover previously lost function. This research is still in the very early phases of development, but the results have been promising and exciting, so I wanted to have Dr. Khoja share his research with you!
Dr. Hamid Khoja, is Chief Scientific Officer for FibroBiologics, a biopharmaceutical and regenerative medicine company, where he leads all research, development, and advancement for the pipeline of fibroblast cell therapy candidates. Hamid has more than 25 years of experience as a leader of scientific teams, in the development of cell-based genomic, proteomic, and epigenetics assays, and of tools, protocols, and technologies for use in drug discovery and development as well as clinical diagnostics.
Hamid has served as the Principal Scientist at Covaris, where he led the effort in successfully incorporating their technology into Illumina Next Generation Sequencing protocols, managed external collaborations for product and applications development, and assessed new technologies for acquisition.
Links:
https://www.linkedin.com/company/fibrobiologics/
https://twitter.com/FibroBiologics
https://www.facebook.com/FibroBiologics
 
 
 Additional Resources: https://www.doctorgretchenhawley.com/insider
Reach out to Me: [email protected] 
Website: www.MSingLink.com
Social: 
★ Facebook: https://www.facebook.com/groups/mswellness
★ Instagram: https://www.instagram.com/doctor.gretchen
★ YouTube: https://www.youtube.com/c/doctorgretchenhawley?sub_confirmation=1
 
→ Game Changers Course: https://www.doctorgretchenhawley.com/GameChangersCourse
→ Total Core Program: https://www.doctorgretchenhawley.com/TotalCoreProgram
→ The MSing Link: https://www.doctorgretchenhawley.com/TheMSingLink 

Ver todos los episodios